Comorbidity in pediatric bipolar disorder
- PMID: 19264265
- PMCID: PMC3757953
- DOI: 10.1016/j.chc.2008.12.005
Comorbidity in pediatric bipolar disorder
Abstract
The growing literature shows the pervasiveness and importance of comorbidity in youth with bipolar disorder (BPD). For instance, up to 90% of youth with BPD have been described to manifest comorbidity with attention-deficit hyperactivity disorder. Multiple anxiety, substance use, and disruptive behavior disorders are the other most commonly reported comorbidities with BPD. Moreover, important recent data highlight the importance of obsessive-compulsive and pervasive developmental illness in the context of BPD. Data suggest that not only special developmental relationships are operant in the context of comorbidity but also that the presence of comorbid disorders with BPD results in a more severe clinical condition. Moreover, the presence of comorbidity has therapeutic implications for the treatment response for both BPD and the associated comorbid disorder. Future longitudinal studies to address the relationship and the impact of comorbid disorders on course and therapeutic response over time are required in youth with BPD.
Figures





Similar articles
-
Pharmacologic treatment of pediatric bipolar disorder.Child Adolesc Psychiatr Clin N Am. 2009 Apr;18(2):455-69, x. doi: 10.1016/j.chc.2008.11.004. Child Adolesc Psychiatr Clin N Am. 2009. PMID: 19264273 Review.
-
Is bipolar disorder specifically associated with panic disorder in youths?J Clin Psychiatry. 2002 May;63(5):414-9. doi: 10.4088/jcp.v63n0507. J Clin Psychiatry. 2002. PMID: 12019666
-
Examining the association between pediatric bipolar disorder and anxiety disorders in psychiatrically referred children and adolescents.J Affect Disord. 2005 Sep;88(1):19-26. doi: 10.1016/j.jad.2005.05.016. J Affect Disord. 2005. PMID: 16043229
-
Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.J Clin Psychopharmacol. 2004 Oct;24(5):512-20. doi: 10.1097/01.jcp.0000138772.40515.70. J Clin Psychopharmacol. 2004. PMID: 15349007
-
Pediatric mania: a developmental subtype of bipolar disorder?Biol Psychiatry. 2000 Sep 15;48(6):458-66. doi: 10.1016/s0006-3223(00)00911-2. Biol Psychiatry. 2000. PMID: 11018219 Review.
Cited by
-
Association between Attention Deficit Hyperactivity Disorder and Suicide Attempts in Patients with Bipolar Disorder.Iran J Psychiatry. 2019 Jul;14(3):242-247. Iran J Psychiatry. 2019. PMID: 31598128 Free PMC article.
-
A Randomized, Double-Blind, Controlled Clinical Trial of Omega-3 Fatty Acids and Inositol as Monotherapies and in Combination for the Treatment of Pediatric Bipolar Spectrum Disorder in Children Age 5-12.Psychopharmacol Bull. 2022 Oct 27;52(4):31-51. Psychopharmacol Bull. 2022. PMID: 36339275 Free PMC article. Clinical Trial.
-
Factors associated with the persistence and onset of new anxiety disorders in youth with bipolar spectrum disorders.J Clin Psychiatry. 2012 Jan;73(1):87-94. doi: 10.4088/JCP.10m06720. Epub 2011 Dec 13. J Clin Psychiatry. 2012. PMID: 22226375 Free PMC article.
-
Effects of comorbid anxiety disorders on the longitudinal course of pediatric bipolar disorders.J Am Acad Child Adolesc Psychiatry. 2014 Jan;53(1):72-81. doi: 10.1016/j.jaac.2013.09.020. Epub 2013 Oct 17. J Am Acad Child Adolesc Psychiatry. 2014. PMID: 24342387 Free PMC article.
-
Anxiety in children with mood disorders: a treatment help or hindrance?J Abnorm Child Psychol. 2012 Apr;40(3):339-51. doi: 10.1007/s10802-011-9568-5. J Abnorm Child Psychol. 2012. PMID: 21912843 Free PMC article. Clinical Trial.
References
-
- Diagnostic and Statistical Manual of Mental Disorders. 4th. Washington, D.C: American Psychiatric Association;
-
- Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity. Arch Gen Psychiatry. 2005;62:1266. - PubMed
-
- Research Units on Pediatric Psychopharmacology Autism Network: Risperidone in children with autism and serious behavioral problems. N Engl J Med. 2002;347:314. - PubMed
-
- Aman MG, Arnold MDL, McDougle CJ, et al. Acute and long-term safety and tolerability of risperidone in children with autism. J Child Adolesc Psychopharmacol. 2005;15:869. - PubMed
-
- Aman MG, De Smedt G, Derivan A, et al. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. Am J Psychiatry. 2002;159:1337. - PubMed